Monaco-based investor James Richman made additional $1.8b from his biotech investments

Probably everyone who has some interest in the financial industry has heard about James Richman. People from his close circle have even gone so far as to compare him with the investment industry’s icon – the one and only Warren Buffet.

Despite his relatively young age, Richman has successfully managed to achieve the amazing decade-long streak of profit returns for his clients.

He became popular due to his investments in many exciting companies with the public ones including Facebook, Uber, and Tesla. One of his most recent successes is his big bet in 3D-printed technologies which reportedly has made him additional $1.8 billion as the demand for 3D-printed medical equipment grows and one of the investors helping the efforts against coronavirus.

The Latvian-born billionaire, who is slowly turning himself into a rock-star of the industry, has been gaining lots of popularity with his investments in the biomedical and technological fields.

While his private investment company, JJ Richman, is not open to the public, it has operations represented in 22 different countries across the globe such as the United Kingdom, Monaco, Hong Kong, Singapore, Russia, Thailand, and Dubai.

The companies he invests in are engaged in different fields like manufacturing, real estate and many others but the “crown jewels'' of his portfolio are the technological research and development projects he backs.

3D Printed Masks

Left: 3D-printed masks, CC 2.0, source: 15th wing. While most of us think of artificial intelligence and 3D-printed human organs as of stuff from science fiction, the investor has been backing such projects and helping them become reality.

As the famous technological entrepreneur Elon Musk has been known for his dream to colonize Mars, Richman’s vision is no less ambitious, since his interest lies in supporting scientists in the field of biotechnology to develop ways to potentially slow down aging and ultimately defeat death.

3D-printed hearts – the dawn of a new era in medicine

The wealthy investor has decided to back a project of a group of Israeli scientists. The research group from Tel Aviv University has delivered the first ever medical breakthroughs in modern days – the first positive testing of 3D-printed hearts from human cells.

James Richman  Wef

Even though the project is still very far from a commercial stage and requires a couple of research milestones to be passed before any conclusions could be made, the results tend to be pretty promising. Until now, scientists have only managed to 3D-print simple tissues without blood vessels.

Despite the fact that the 3D-printed heart is the size of a rabbit’s heart, the successful 3D-printing of a live, functioning organ is a tremendous progress.

First medical breakthrough

The Israeli researchers emphasize on the fact that the bulk material for the 3D-printing are human cells and the long-term idea is to use a patient’s own cells for the printing of the organ.

This way the issue of organ rejection after transplantations, which is a major problem in such kinds of medical interventions nowadays, could be solved.

The next steps ahead of the project would be testing out the organs in animal models and then eventually printing human hearts and clinical trials with human patients.

It is uncertain when and if this technology would become a routinely conducted procedure, but one can tell for sure, that with an investor like James Richman behind its back, we’ll definitely be hearing more from it.

Follow EU Today on Social media:

EUToday Correspondents

EUToday Correspondents

Our team of independent correspondents, based across Europe and beyond, are at the centre of geopolitical dynamics. We are united by our commitment to free and unbiased journalism, and our devotion to the concept of true and unfettered democracy. We take our job very seriously!

Related posts